Background: Coronary artery disease (CAD) is major global concerns.CAD can cause more than 23 million deaths in 2030 around the world. Improvement of patients` life style practices are achieved by effective utilization of an educational program. Aim: This study aimed to evaluate the effect of implementing an educational program on life style practices among patients with CAD.

Background: Throughout the first three months following discharge from the hospital, patients who have undergone coronary artery bypass graft surgery (CABG) frequently have a wide range of symptoms, which affect the quality of life (QOL) by adding extra burdens to their health. The study aimed to determine the relationship between symptom burden clusters and the quality of life in patients with coronary artery bypass graft surgery. Research design: A descriptive correlational design was utilized in this study. Setting and sampling A purposive sample of 85 post-CABG surgery patients was investigated at the cardiac outpatient clinic affiliated with Suez Canal University Hospitals. Tools: Tool I: A structured interview questionnaire, Tool II: The cardiac symptom survey (CSS) to measure the burden of symptoms for patients who have undergone CABG surgery, Tool III: The World Health Organization Quality of Life questionnaire (WHOQOL-BREF), which measures patients' quality of life. Results: The study found that lowmoderate symptom burden affected 35.3% of the patients, moderate symptom burden involved 47.05%, and low symptom burden affected 17.65%. The mean score for physical health was the greatest at 62.04±11.65, followed by perceptual health at 60.24±7.93, economic health at 59.886.81, social health at 57.61±7.62, and emotional health at 55.63±7.89. Conclusion: There is a statistically significant relationship between total symptom burden and physical, social, and emotional health, and this relationship increases with every unit increase in the symptom burden score. Recommendations: Conduct research to assess how a self-care program affects patients with CABGs' symptom burden and quality of life.

Background: Medication adherence and Quality of Life (QoL) are two integral factors for sustaining optimal health; where medication non-adherence of Hepatitis C virus patients predisposes them to poor prognosis and remarkably low QoL. This study aimed to explore the effect of medication adherence practices on the quality of life among newly treated hepatitis "C" virus (HCV) patients. Methods: The researchers used a quasi-experimental research design. Setting: The study was conducted at the Hepatology Outpatient Clinic of Alexandria Main University Hospital. Subjects: A purposive non-probability sample of 100 adult newly treated HCV patients (≤12 months) were enrolled. Tools: The researchers used three tools for collecting data. Firstly, Sociodemographic and Clinical Data sheet, secondly Morisky Medication Adherence Scale 8 items (MMAS-8), and thirdly, the World Health Organization Quality of Life abbreviated version (WHOQoL-BREF) Questionnaire. Results: A highly significant difference was obvious between all medication adherence items of studied patients at the pre, one-month, and three months post-tests. Where the mean total QoL score was increased after three months of follow-up than from the preintervention with a highly significant difference. Additionally, a highly positive correlation between medication adherence and QoL was detected in pre, one-month, and three months follow-up periods. Conclusion: the mean total QoL score of the studied HCV patients was improved, with a high positive correlation between medication adherence and QoL in newly treated studied HCV patients.

Medication adherence and Quality of Life (QoL) are two integral factors for sustaining optimal health; where medication non-adherence of Hepatitis C virus patients predisposes them to poor prognosis and remarkably low QoL. This study aimed to explore the effect of medication adherence practices on the quality of life among newly treated hepatitis "C" virus (HCV) patients. Methods:The researchers used a quasi-experimental research design. Setting: The study was conducted at the Hepatology Outpatient Clinic of Alexandria Main University Hospital. Subjects: A purposive nonprobability sample of 100 adult newly treated HCV patients (≤12 months) were enrolled. Tools: The researchers used three tools for collecting data. Firstly, Sociodemographic and Clinical Data sheet, secondly Morisky Medication Adherence Scale 8 items (MMAS-8), and thirdly, the World Health Organization Quality of Life abbreviated version (WHOQoL-BREF) Questionnaire. Results: A highly significant difference was obvious between all medication adherence items of studied patients at the pre, one-month, and three months post-tests. Where the mean total QoL score was increased after three months of follow-up than from the pre-intervention with a highly significant difference. Additionally, a highly positive correlation between medication adherence and QoL was detected in pre, one-month, and three months follow-up periods. Conclusion: the mean total QoL score of the studied HCV patients was improved, with a high positive correlation between medication adherence and QoL in newly treated studied HCV patients.